VB 1953

Drug Profile

VB 1953

Alternative Names: VB-1953

Latest Information Update: 02 May 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Vyome Biosciences
  • Class Anti-infectives; Anti-inflammatories; Antiacnes; Antibacterials
  • Mechanism of Action Bacterial DNA inhibitors; Bacterial growth inhibitors; Bacterial protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Acne

Most Recent Events

  • 24 Apr 2017 Vyome Biosciences completes enrolment in its proof-of-concept trial for Acne in Central America and Dominican Republic
  • 07 Feb 2017 Adverse events, efficacy and pharmacokinetics data from a phase I trial in Acne released by Vyome Biosciences
  • 07 Feb 2017 Vyome Biosciences plans a phase II trial for Acne
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top